ProCE Banner Activity

Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes


Download this comprehensive slideset for the latest data on integrating CAR T-cell therapy into the management of DLBCL, FL, MCL, and CLL/SLL to improve patient outcomes.

Released: June 13, 2023



Michael R. Bishop

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

Kathleen Dorritie

Kathleen Dorritie, MD

Assistant Professor of Medicine
Division of Hematology/Oncology
UPMC Hillman Cancer Center,
University of Pittsburgh
Pittsburgh, Pennsylvania

Julie M. Vose

Julie M. Vose, MD, MBA

Newmann M. and Milde E. Harris Professor
Chief, Hematology/Oncology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb